Laura Tadvalkar, Ph.D.

Laura Tadvalkar is a Principal on the venture team at RA Capital Management. Laura works on new company creation and early-stage investments and serves on the board of directors of Expansion Therapeutics, Hemab, and Aliada Therapeutics. Laura has a B.S. in Chemistry from Yale University and a Ph.D. in Chemical Biology from Harvard University. Prior to RA, Laura was a Principal at MP Healthcare Venture Management. Prior to MP, she was a Consultant at Clarion Healthcare.